Autoimmune Pulmonary Alveolar Proteinosis with Suspected Exacerbation after Osimertinib Administration for Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autoimmune Pulmonary Alveolar Proteinosis with Suspected Exacerbation after Osimertinib Administration for Lung Cancer

Published:2023-04-15 Issue:8 Volume:62 Page:1203-1206
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Shimoda Masafumi¹,Ishii Haruyuki²,Tanaka Yoshiaki¹,Morimoto Kozo¹,Takemura Tamiko³,Oka Teruaki⁴,Yoshimori Kozo¹,Ohta Ken¹

Affiliation:

1. Respiratory Disease Center, Fukujuji Hospital, Japan Anti-tuberculosis Association, Japan

2. Department of Respiratory Medicine, Kyorin University School of Medicine, Japan

3. Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, Japan

4. Department of Pathology, Japan Anti-tuberculosis Association Fukujuji Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/8/62_0256-22/_pdf

Reference16 articles.

1. 1. McCarthy C, Carey BC, Trapnell BC. Autoimmune pulmonary alveolar proteinosis. Am J Respir Crit Care Med 205: 1016-1035, 2022.

2. 2. Trapnell BC, Nakata K, Bonella F, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers 5: 16, 2019.

3. 3. Jouneau S, Menard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology 25: 816-826, 2020.

4. 4. Hiraki T, Goto Y, Kitazono I, et al. The first case of pulmonary alveolar proteinosis with small cell lung carcinoma. Int J Surg Pathol 24: 135-138, 2016.

5. 5. Zhang N, Li Q, Shao C. Pulmonary alveolar proteinosis with peripheral adenocarcinom. Sarcoidosis Vasc Diffuse Lung Dis 35: 390-394, 2018.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary alveolar proteinosis complicated by lung cancer with favorable prognosis: a case report and literature review;Frontiers in Oncology;2024-09-12

2. Multiple drugs;Reactions Weekly;2023-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3